Sbi Investment Korea Co., Ltd. - Oct 7, 2024 Form 4 Insider Report for Peak Bio, Inc. (PKBO)

Role
Director
Signature
/s/ Jae Kwang Ahn, Authorized Person SBI Investment Korea Co., Ltd.
Stock symbol
PKBO
Transactions as of
Oct 7, 2024
Transactions value $
$0
Form type
4
Date filed
12/4/2024, 08:30 AM
Previous filing
Feb 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PKBO Common Stock Other $0 -83.8K -100% $0.00 0 Oct 7, 2024 Direct F1
transaction PKBO Common Stock Disposed to Issuer -3.62M -100% 0 Nov 14, 2024 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sbi Investment Korea Co., Ltd. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 On October 7, 2024 (October 8, 2024 Korea time), in connection with the dissolution of SBI KIS 2016-1 FUND ("2016-1 Fund"), 2016-1 Fund distributed in-kind, for nominal consideration, all of the securities of the Issuer owned by 2016-1 Fund to SBI Investment KOREA Co., Ltd. ("SBI"), the general partner of 2016-1 Fund.
F2 This Form 4 reports securities transacted pursuant to the terms of the Agreement and Plan of Merger, dated as of March 4, 2024, as amended (the "Merger Agreement"), by and among the Issuer, Akari Therapeutics Plc ("Parent"), and Pegasus Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of November 14, 2024, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger").
F3 Consists of 571,606 shares of common stock held by SBI, 251,418 shares of common stock held by SBI Cross-border Advantage Fund, an affiliate of SBI, 599,202 shares of common stock held by SBI Healthcare Fund 1, an affiliate of SBI, 1,601,067 shares of common stock held by IBKC-SBI Bio Fund 1, an affiliate of SBI, 419,017 shares of common stock held by Global Gateway Fund 1, an affiliate of SBI, and 179,179 shares of common stock held by 2019 SBI Job Creation Fund, an affiliate of SBI.
F4 At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock was cancelled and converted into the right to receive 0.2935 (the "Exchange Ratio") American Depositary Shares ("ADSs") of Parent, each ADS representing a number of ordinary shares, par value $0.0001 per share (the "Ordinary Shares") of Parent.